Wei Ding
Director/Board Member at Lu Daopei Medical Group Holding Ltd.
Profile
Wei Ding is currently the Director at Beijing Ludaopei Biotechnology Co., Ltd, Non-Executive Director at Lu Daopei Medical Group Holding Ltd., and Director at Synarc Research Laboratory Beijing Ltd.
Previously, he worked as a Managing Director at C-Bridge Capital Investment Advisor Ltd.
Mr. Ding received his graduate degree from the University of International Business & Economics in 2002 and his undergraduate degree from Xiamen University.
Wei Ding active positions
Companies | Position | Start |
---|---|---|
Lu Daopei Medical Group Holding Ltd.
Lu Daopei Medical Group Holding Ltd. Hospital/Nursing ManagementHealth Services Lu Daopei Medical Group Holding Ltd. provides hematology treatment services. It built full-cycle hematology specialty service capabilities by integrating various treatments such as HSCTs, chemotherapy, targeted therapy, immunotherapy, and a combination of these, and offering hematology esoteric testing services throughout the whole diagnosis and treatment course. The company was founded on October 05, 2021 and is headquartered in Beijing, China. | Director/Board Member | 19/07/2022 |
Beijing Ludaopei Biotechnology Co., Ltd | Director/Board Member | 31/10/2017 |
Synarc Research Laboratory Beijing Ltd. | Director/Board Member | 31/05/2018 |
Former positions of Wei Ding
Companies | Position | End |
---|---|---|
C-Bridge Capital Investment Advisor Ltd. | Chief Executive Officer | - |
Training of Wei Ding
University of International Business & Economics | Graduate Degree |
Xiamen University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
C-Bridge Capital Investment Advisor Ltd. | |
Beijing Ludaopei Biotechnology Co., Ltd | |
Lu Daopei Medical Group Holding Ltd.
Lu Daopei Medical Group Holding Ltd. Hospital/Nursing ManagementHealth Services Lu Daopei Medical Group Holding Ltd. provides hematology treatment services. It built full-cycle hematology specialty service capabilities by integrating various treatments such as HSCTs, chemotherapy, targeted therapy, immunotherapy, and a combination of these, and offering hematology esoteric testing services throughout the whole diagnosis and treatment course. The company was founded on October 05, 2021 and is headquartered in Beijing, China. | Health Services |
Synarc Research Laboratory Beijing Ltd. |
- Stock Market
- Insiders
- Wei Ding